UKAS/CPA partnership a milestone in international labs accreditation:
This article was originally published in Clinica
The UK Accreditation Service and the UK's Clinical Pathology Accreditation (CPA) have described the recent ISO 15189:2003 accreditation of laboratory services in Mexico as a milestone in international activities in this area. Mexican pathology and diagnostic services group Grana SA/ Laboratorios Dr Moreira (Monterrey, Nuevo Leon) was the recipient of the first accreditation under a UKAS/CPA partnership. The assessment also involved New Zealand and Mexican counterparts IANZ and EMA as observers. The UKAS/CPA partnership was established to "strengthen the authority and reputation of accreditation in the UK and internationally, by bringing together two organisations with established reputations in their respective fields".
You may also be interested in...
The regulatory agency also urges qualified persons at drug companies to let the agency know as soon as possible if they are finding that the new measures are not flexible enough to deal with the current logistical challenges quickly.
The Swiss biotech's focal-onset seizure therapy, which is licensed from South Korea's SK and is already approved in the US, could have potential in indications beyond epilepsy, Arvelle's CEO tells Scrip.
Biocon has reported FDA clearance for its Malaysian insulin facility, while Lupin and Xellia have also received plant approvals. Meanwhile, Alembic has seen mixed fortunes, receiving both Form 483 observations and an EIR.